Voyager stockholders approve 2025 stock plans, elect directors at annual meeting

Voyager Therapeutics, Inc.

Approved 2025 Stock Incentive Plan: 28.6M for, 11.3M against, 8.5M broker non-votes.
Approved Amended and Restated 2015 ESPP: 36.5M for, 3.3M against, 8.5M broker non-votes.
Elected Class I directors Colón, Mackey, Pierce, Scangos; Scangos had 6.7M votes withheld.
Ratified Ernst & Young as FY2025 auditor: 48.1M for, 0.25M against.
Say-on-pay approved: 37.8M for, 2.0M against, 0.1M abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.